Working to protect what's most precious to you

Deighton Bowie has a clear purpose: to improve the lives of individuals, families and communities by protecting what is precious to them.

About Us

Established in 2013 Deighton Bowie was founded on drawing together expertise in legal and accountancy services. We have been working with charities and community groups for over three decades.

We know that our business thrives on reputation, and each time a referral is made we make a donation to charity. See here a list of those organisations we regularly support.

We make sure our clients are at the centre of all we do, and as far as possible we tailor our approach to each individual set of circumstances. There is no off the shelf provision. We invest our time in ensuring you understand the options available and making sure you feel involved.

We will come to you, and during the advice phase we offer guidance and information to make sure that you understand clearly the choices you are making. Our mission is to make the area of law you are dealing with feel accessible and clear, breaking down any barriers of mystery and technical language.

When it is needed, we deliver on a pro bono basis wherever we can, and our strong network of partnerships gives us the ability to draw on the support, expertise and goodwill of professional advisers and caseworkers who will contribute.

Organisations We Support

For 2020 our chosen charities are the addictions work of Fundatia Increderea and Target Ovarian Cancer.

Fundatia Increderea

Fundatia Increderea (FI) began its work in Romania in the 1990s as the world looked on in horror at an underground orphanage system exposed, a generation of children kept in desperate conditions.

Today, those thousands of tiny faces are adults. For many, a broken childhood has left its legacy in the form of a broken life.

Target Ovarian Cancer

Target Ovarian Cancer is the UK’s leading ovarian cancer charity. They work to improve early diagnosis, fund life-saving research and provide much-needed support to women with ovarian cancer.